Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA
Dr O'Reilly presents on his work looking at the development of Epstein-Barr virus– specific cytotoxic T lymphocyte (EBV-CTL) therapy in the treatment of leukaemia and lymphoma during a press conference at AACR 2015.